Search results

525 results found.

Notice – Tariff for insured hearing aids and related services, February 14, 2018
/en/media/981
Tariff for insured devices which compensate for a motor deficiency and related services, March 1, 2017
/en/media/986
Notice of alternative medication authorization, May 10, 2023
/en/media/14896
This notice was published on May 26, 2023.
- Prazosin hydrochloride, tablets and capsules, 1 mg replaces Teva-Prazosin, tablets, 1 mg
- Prazosin hydrochloride, tablets and capsules, 2 mg replaces Teva-Prazosin, tablets, 2 mg
- Prazosin hydrochloride, tablets and capsules, 5 mg replaces Teva-Prazosin, tablets, 5 mg
Ocular prostheses or artificial eyes
/en/citizens/aid-programs/ocular-prostheses-artificial-eyes
The Ocular Prostheses Program provides financial assistance for the purchase, maintenance and replacement of ocular prostheses (artificial eyes).
Notice of alternative medication authorization, October 14, 2022
/en/media/13996
This notice was published on October 26, 2022.

Haloperidol replaces Teva-Haloperidol.
Notice of alternative medication authorization, October 14, 2022
/en/media/14196
This notice was published on November 29, 2022.

Haloperidol replaces Teva-Haloperidol.
Notice of alternative medication authorization, November 29, 2023
/en/media/16026
This notice was published on February 1, 2024.

Fluvastatine sodium replaces Teva Fluvastatin.
Notice of alternative medication authorization, August 21, 2024
/en/media/18531
This notice was published on September 10, 2024.

Gemfibrozil replaces Teva-Gemfibrozil.
Notice of alternative medication authorization, June 25, 2025
/en/media/25471
This notice was published on June 25, 2025.
Piroxicam replaces Teva-Piroxicam.
Notice – Tariff for insured hearing aids and related services, February 16, 2016
/en/media/12166

Search results

How did we do?